Previous literature has suggested a potential role for AIMp1 in TH1 immunity (16–22, 45–47), and our work demonstrated BMDC-expressed AIMp1 is required for vaccine-mediated melanoma tumor rejection. This evidence concerns the gene AIMP1 and neoplasm.